Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer

2023
CME
NMSC
This live hybrid program will explore key clinical practice insights for patients with advanced and high-risk resectable NMSC
Authors

David M. Miller

Sailesh Konda

Published

May 6, 2023

Event

Med Learning Group CME Programming. Event URL

Overview

This live activity is designed to help healthcare professionals:

  1. Examine clinical trials data supporting the use of new systemic immunotherapy for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation

  2. Describe risk assessment of patients with NMSCs who may derive greater benefit from new systemic therapies as opposed to Mohs surgery

  3. Review the coordination and collaboration of multidisciplinary team members in the management of patients with advanced NMSCs failing or not amenable to surgery or radiation

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement